Literature DB >> 35241558

Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma.

Kosei Takagi1, Yasuo Nagai2, Yuzo Umeda2, Ryuichi Yoshida2, Kazuhiro Yoshida2, Tomokazu Fuji2, Kenjiro Kumano2, Kazuya Yasui2, Takahito Yagi2, Toshiyoshi Fujiwara2.   

Abstract

BACKGROUND/AIM: The optimal extent of lymph node dissection for ampullary carcinoma is controversial. The aim of this study was to investigate the efficacy of lymph node dissection for ampullary carcinoma. PATIENTS AND METHODS: Between 2000 and 2020, a total of 75 patients undergoing radical resection for ampullary carcinoma were included. The efficacy index (EI) was calculated by multiplication of the frequency of lymph node metastasis (LNM) at the station and the 5-year survival rate of patients with metastasis at the station.
RESULTS: Out of 75 patients, 14 had LNM. The EI for the peri-pancreatic head (station 13 and 17) and superior mesenteric artery (station 14) lymph node were 4.4 and 3.5, respectively. Whereas the peri-gastric (station 5 and 6), common hepatic artery (station 8), and liver hilum (station 12) lymph node stations had zero EI. Although the number of patients with the station 16 dissected was small (9%), the para-aortic (station 16) lymph nodes had the highest EI of 14.3 despite being distant lymph nodes.
CONCLUSION: We identified the distribution of LNM and survival benefit of lymph node dissection for ampullary carcinoma. Our results suggest that the optimal extent of lymph node dissection for ampullary carcinoma could be reconsidered.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Ampullary carcinoma; carcinomas of the papilla of Vater; lymph node dissection; outcome

Mesh:

Year:  2022        PMID: 35241558      PMCID: PMC8931900          DOI: 10.21873/invivo.12789

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

1.  Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy.

Authors:  Inger Marie Bowitz Lothe; Dyre Kleive; Ewa Pomianowska; Milada Cvancarova; Elin Kure; Svein Dueland; Ivar P Gladhaug; Knut Jørgen Labori
Journal:  Pancreatology       Date:  2019-01-25       Impact factor: 3.996

2.  New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.

Authors:  M Sasako; P McCulloch; T Kinoshita; K Maruyama
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

3.  Prognostic significance of regional lymph node metastasis according to station in ampullary carcinoma.

Authors:  Keita Tashiro; Naomi Kuroki; Takahiro Einama; Toshimitsu Iwasaki; Yoichi Miyata; Suefumi Aosasa; Yosuke Inoue; Yu Takahashi; Sho Ogata; Hideki Ueno; Kazuo Hase; Junji Yamamoto; Yoji Kishi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2020-06-23       Impact factor: 7.027

4.  Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: A systematic review and meta-analysis.

Authors:  Nguyen-Phong Vo; Hung Song Nguyen; El-Wui Loh; Ka-Wai Tam
Journal:  Surgery       Date:  2021-04-23       Impact factor: 3.982

5.  Long-term survival and recurrence patterns in ampullary cancer.

Authors:  Palat Balachandran; Sadiq S Sikora; Shalini Kapoor; Narendra Krishnani; Ashok Kumar; Rajan Saxena; Vinay K Kapoor
Journal:  Pancreas       Date:  2006-05       Impact factor: 3.327

6.  Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.

Authors:  Sang Myung Woo; Ji Kon Ryu; Sang Hyub Lee; Ji Won Yoo; Joo Kyung Park; Yong-Tae Kim; Jin-Young Jang; Sun-Whe Kim; Gyeong Hoon Kang; Yong Bum Yoon
Journal:  Ann Surg Oncol       Date:  2007-08-19       Impact factor: 5.344

7.  Reconsidering the Optimal Regional Lymph Node Station According to Tumor Location for Pancreatic Cancer.

Authors:  Taisuke Imamura; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Ann Surg Oncol       Date:  2020-08-29       Impact factor: 5.344

8.  Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition.

Authors:  Masato Nagino; Satoshi Hirano; Hideyuki Yoshitomi; Taku Aoki; Katsuhiko Uesaka; Michiaki Unno; Tomoki Ebata; Masaru Konishi; Keiji Sano; Kazuaki Shimada; Hiroaki Shimizu; Ryota Higuchi; Toshifumi Wakai; Hiroyuki Isayama; Takuji Okusaka; Toshio Tsuyuguchi; Yoshiki Hirooka; Junji Furuse; Hiroyuki Maguchi; Kojiro Suzuki; Hideya Yamazaki; Hiroshi Kijima; Akio Yanagisawa; Masahiro Yoshida; Yukihiro Yokoyama; Takashi Mizuno; Itaru Endo
Journal:  J Hepatobiliary Pancreat Sci       Date:  2020-12-23       Impact factor: 7.027

9.  Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction.

Authors:  Ming-Zhi Cai; Chen-Bin Lv; Li-Sheng Cai; Qiu-Xian Chen
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.